Nature Biochem
Nature Biochem is a Private Indian company incorporated in 2009 and based in Karnataka, India. Nature Biochem operates in Pharmaceuticals & Chemicals (NIC 24119) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Nature Biochem - Manufacturer of Biochemicals.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Nature Biochem.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +14d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +18d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Nature Biochem.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 234712508 | State Bank of India(Bank) | ₹9.45 Cr | 19 Sep 2020 | Open |
| 911351814 | ICICI Bank Ltd(Bank) | ₹17.59 Cr | 04 Jul 2021 | Satisfied |
| 598911930 | Axis Bank Ltd(Bank) | ₹20.55 Cr | 04 Jul 2023 | Open |
| 796021722 | Kotak Mahindra Bank Ltd(Bank) | ₹3.23 Cr | 27 Jan 2023 | Open |
| 919044554 | Axis Bank Ltd(Bank) | ₹16.66 Cr | 27 Jan 2020 | Satisfied |
| 472513257 | State Bank of India(Bank) | ₹8.28 Cr | 04 Jul 2020 | Satisfied |
Charge IDs, lenders & amounts for Nature Biochem.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹76.99 Cr | ₹5.07 Cr | ₹41.47 Cr | ₹90.09 Cr | 69 |
| FY2023-24 | ₹68.48 Cr | ₹6.10 Cr | ₹60.85 Cr | ₹105.01 Cr | 238 |
| FY2022-23 | ₹49.32 Cr | ₹4.03 Cr | ₹29.72 Cr | ₹63.86 Cr | 210 |
| FY2021-22 | ₹37.03 Cr | ₹2.87 Cr | ₹37.91 Cr | ₹62.88 Cr | 99 |
Audited financials & ratios for Nature Biochem.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹76.99 Cr | ₹68.48 Cr | ₹49.32 Cr | ₹37.03 Cr |
| Other income | ₹2.44 Cr | ₹2.33 Cr | ₹1.84 Cr | ₹99.79 L |
| Total income | ₹79.43 Cr | ₹70.81 Cr | ₹51.16 Cr | ₹38.02 Cr |
| Total expenses | ₹72.94 Cr | ₹63.01 Cr | ₹46.00 Cr | ₹34.35 Cr |
| Profit before tax | ₹6.59 Cr | ₹7.93 Cr | ₹5.23 Cr | ₹3.73 Cr |
| Profit / (Loss) after tax | ₹5.07 Cr | ₹6.10 Cr | ₹4.03 Cr | ₹2.87 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹41.47 Cr | ₹60.85 Cr | ₹29.72 Cr | ₹37.91 Cr |
| Borrowings | ₹21.23 Cr | ₹20.61 Cr | ₹13.05 Cr | ₹10.15 Cr |
| Current liabilities | ₹15.73 Cr | ₹18.93 Cr | ₹12.24 Cr | ₹11.61 Cr |
| Total liabilities | ₹48.62 Cr | ₹44.16 Cr | ₹34.14 Cr | ₹24.97 Cr |
| Current assets | ₹34.80 Cr | ₹50.22 Cr | ₹35.31 Cr | ₹31.73 Cr |
| Cash & equivalents | ₹11.91 Cr | ₹15.41 Cr | ₹5.01 Cr | ₹11.48 Cr |
| Total assets | ₹90.09 Cr | ₹105.01 Cr | ₹63.86 Cr | ₹62.88 Cr |
| Employees | 69 | 238 | 210 | 99 |
Audited financials & ratios for Nature Biochem.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹76.99 Cr | +26.1% | +5.6% | +14.1% |
| Profit after Tax | ₹5.07 Cr | +25.3% | +26.5% | +14.9% |
| Net Worth | ₹41.47 Cr | -2.0% | +2.5% | +4.2% |
| Employees | 69 | +12.4% | +22.0% | +7.8% |
Audited financials & ratios for Nature Biochem.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹76.99 Cr | ₹5.07 Cr | +6.58% | +1.31% | +12.22% | +5.63% | 0.51 | ₹1.12 Cr |
| FY2023-24 | ₹68.48 Cr | ₹6.10 Cr | +8.90% | -6.78% | +10.02% | +5.81% | 0.34 | ₹28.77 L |
| FY2022-23 | ₹49.32 Cr | ₹4.03 Cr | +8.16% | +14.45% | +13.55% | +6.31% | 0.44 | ₹23.48 L |
| FY2021-22 | ₹37.03 Cr | ₹2.87 Cr | +7.74% | -2.87% | +7.56% | +4.56% | 0.27 | ₹37.40 L |
Audited financials & ratios for Nature Biochem.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,89,84,258 | 87.10% |
| Institutional Investors | 3 | 5,96,974 | 2.74% |
| Public & Others | 58 | 22,14,228 | 10.16% |
Promoter, institutional & public holding for Nature Biochem.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
18 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.